CU Healthcare Innovation Fund

ClinOne, Inc. is a technology company that specializes in mobile software applications designed for clinical trial management. Founded in 2013 and based in Greenwood Village, Colorado, ClinOne's platform enhances the interaction and engagement between researchers and patients by transitioning clinical trial processes to a mobile environment. The application offers a comprehensive suite of tools that centralizes research data, streamlines site workflow, and facilitates communication among investigators and research staff across large institutions. ClinOne's solutions aim to improve clinical trial enrollment, retention, site compliance, and overall patient experience. The company's client roster includes notable organizations in the pharmaceutical and medical device sectors, such as Array Biopharma, Genentech, Actelion, Takeda, and Boston Scientific.

Eon Health is a healthcare technology company based in Denver, Colorado, that specializes in providing software solutions for complex patient management. Established in 2015 as Matrix Analytics and rebranded in 2018, Eon Health focuses on revolutionizing the collection, curation, and sharing of healthcare data among professionals. Its flagship software platform, EonDirect, integrates with existing electronic health record (EHR) systems to deliver actionable insights through an online dashboard, enabling healthcare providers to effectively diagnose and treat complex diseases. The company currently collaborates with 31 hospitals and manages the care of over 12,000 patients, ensuring that critical data reaches the appropriate stakeholders in a timely manner.

Cured, Inc. is a healthcare technology company that specializes in digital marketing and customer relationship management solutions for the healthcare sector. Founded in 2018 and headquartered in San Francisco, California, with additional offices in Chicago and Denver, Cured develops a cloud-based platform that integrates various tools to enhance patient engagement and streamline operations for healthcare organizations. The company's offerings include network management, patient marketing, and insights, aimed at improving customer experiences and healthcare outcomes. By creating custom content and utilizing pre-built templates, Cured enables healthcare providers to foster better interactions with patients and unify processes and technology to enhance efficiencies and care quality.

ClinOne, Inc. is a technology company that specializes in mobile software applications designed for clinical trial management. Founded in 2013 and based in Greenwood Village, Colorado, ClinOne's platform enhances the interaction and engagement between researchers and patients by transitioning clinical trial processes to a mobile environment. The application offers a comprehensive suite of tools that centralizes research data, streamlines site workflow, and facilitates communication among investigators and research staff across large institutions. ClinOne's solutions aim to improve clinical trial enrollment, retention, site compliance, and overall patient experience. The company's client roster includes notable organizations in the pharmaceutical and medical device sectors, such as Array Biopharma, Genentech, Actelion, Takeda, and Boston Scientific.

IMTherapeutics is a biotechnology company focused on creating personalized immunotherapeutic drugs for autoimmune diseases, utilizing genetic insights linked to human leukocyte antigen (HLA) genes. Founded in 2015 and based in Aurora, Colorado, the company’s lead candidate is an oral medication designed to inhibit the autoimmune process in type 1 diabetes (T1D) by targeting specific immune cells. This approach aims to preserve the function of pancreatic beta cells and support normal insulin production in patients at risk or in the early stages of T1D. Additionally, IMTherapeutics is leveraging its HLA platform to expand its drug pipeline to include treatments for Celiac disease and potentially other autoimmune disorders. The company employs advanced screening techniques and rational drug design to develop targeted therapeutic candidates, enhancing early detection and management of autoimmune conditions.